CompanyDrug

Yantai Dongcheng Pharmaceutical Gets Singapore HSA Nod for Phase I Study of 177Lu-LNC1003

CompanyDeals

SanegeneBio Partners with Huadong Medicine to Develop RNAi Therapeutics for Metabolic Diseases

CompanyDrug

Chongqing Lummy Pharmaceutical’s Generic Ramosetron Passes GQCE in China

CompanyDeals

Shanghai Qingyun Pharmaceutical Teams Up with Organon at CIIE for Remeron Marketing

CompanyMedical Device

Sino Medical Sciences Technology Secures EU MDR Approval for HT Supreme Drug-Eluting Stent System

CompanyDeals

Biosmelt Pharma Partners with Shenzhen Eureka Biotechnology for Cell and Gene Therapy Advancements

CompanyDeals

Bayer Secures Multiple Procurement Deals at the 6th CIIE

CompanyDeals

ayer Partners with Changzhou Qianhong Bio-pharma to Advance Digestive Health Solutions

CompanyDrug

Sirius Therapeutics Pursues First-in-Human Trial for SRSD107 in Australia

CompanyDrug

ImmVira’s MVR-T3011 IV Achieves Positive Outcomes in US Phase I Clinical Study

CompanyMedical Device

Establishment Labs Receives NMPA Approval for Motiva Silicone Gel-Filled Breast Implants

Company

AstraZeneca Reports Q3 2023 Revenue Growth and Oncology Milestones